001441881 000__ 04310cam\a2200553\a\4500
001441881 001__ 1441881
001441881 003__ OCoLC
001441881 005__ 20230309003347.0
001441881 006__ m\\\\\o\\d\\\\\\\\
001441881 007__ cr\un\nnnunnun
001441881 008__ 220219s2021\\\\sz\\\\\\o\\\\\000\0\eng\d
001441881 019__ $$a1296085360$$a1296116500$$a1296424611
001441881 020__ $$a3030851095
001441881 020__ $$a9783030851095$$q(electronic bk.)
001441881 020__ $$z3030851087
001441881 020__ $$z9783030851088
001441881 0247_ $$a10.1007/978-3-030-85109-5$$2doi
001441881 035__ $$aSP(OCoLC)1298394823
001441881 040__ $$aEBLCP$$beng$$epn$$cEBLCP$$dGW5XE$$dYDX$$dOCLCO$$dOCLCF$$dN$T$$dOCLCQ
001441881 049__ $$aISEA
001441881 050_4 $$aRC114.5
001441881 08204 $$a616.9/1$$223
001441881 24500 $$aCoronavirus therapeutics.$$nVolume I,$$pBasic science and therapy development /$$cAlexzander A.A. Asea, Punit Kaur, editors.
001441881 24630 $$aBasic science and therapy development
001441881 260__ $$aCham :$$bSpringer,$$c2021.
001441881 300__ $$a1 online resource (225 pages)
001441881 336__ $$atext$$btxt$$2rdacontent
001441881 337__ $$acomputer$$bc$$2rdamedia
001441881 338__ $$aonline resource$$bcr$$2rdacarrier
001441881 4901_ $$aAdvances in experimental medicine and biology ;$$vv. 1352
001441881 5050_ $$aOrigin and structural biology of Novel Coronavirus (SARS-CoV-2) -- The Molecular Virology of Coronaviruses with Special Reference to SARS-CoV-2 -- Epidemiology, transmission and molecular immunopathology of SARS-CoV-2 -- Epidemiology and Etiopathogeny of Covid-19 -- Immunological and Hematological Response in COVID-19 -- Toll-like receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological Perspective -- Potential drug strategies to target Coronaviruses -- Possible therapeutic intervention strategies for COVID-19 by manipulating the cellular proteostasis network -- The potential impact of statins in the treatment of patients with COVID-19 infection -- Anticoronavirus activity of water-soluble pristine C60 fullerenes: in vitro and in silico screening -- Application of Nanoscale materials and nanotechnology against viral infection: A special focus on Coronaviruses -- Obesity: A Risk Factor for Covid-19 -- Cytokine Storm and Failed Resolution in COVID-19: Taking Cue from Multiple Sclerosis.
001441881 506__ $$aAccess limited to authorized users.
001441881 520__ $$aThe book Coronavirus Therapeutics Volume I provides the most comprehensive review on contemporary knowledge on the origin, structural biology and molecular aspects of Coronaviruses. It also describes the etiology and pathogeny and therapeutic targets including vaccine drug candidates against Coronaviruses in the light of current scientific knowledge. Using an integrative approach to the understanding of Coronaviruses structure, function and immunobiology, the contributors provide a synopsis of novel mechanisms by which Coronaviruses can be treated. Key basic and clinical research laboratories from major universities, academic medical hospitals, biotechnology and pharmaceutical laboratories around the world have contributed articles that review present research activity on the role of heat shock proteins in human diseases and importantly project the field into the future. The book is a must read for graduate students. medical students, basic science researchers and postdoctoral scholars in the fields of Cancer Biology, Oncology, Cardiovascular Diseases, Microbiology, Inflammation, Translational Medicine, Clinical Research, Biotechnology, Cell & Molecular Medicine, Pharmaceutical Scientists and Researchers involved in Drug Discovery.
001441881 588__ $$aDescription based on print version record.
001441881 650_0 $$aCoronavirus infections.
001441881 650_0 $$aCoronavirus infections$$xTreatment.
001441881 650_6 $$aInfections à coronavirus.
001441881 650_6 $$aInfections à coronavirus$$xTraitement.
001441881 655_0 $$aElectronic books.
001441881 7001_ $$aAsea, Alexzander A. A.
001441881 7001_ $$aKaur, Punit.
001441881 77608 $$iPrint version:$$aAsea, Alexzander A.A.$$tCoronavirus Therapeutics - Volume I.$$dCham : Springer International Publishing AG, ©2022$$z9783030851088
001441881 830_0 $$aAdvances in experimental medicine and biology ;$$vv. 1352.
001441881 852__ $$bebk
001441881 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-85109-5$$zOnline Access$$91397441.1
001441881 909CO $$ooai:library.usi.edu:1441881$$pGLOBAL_SET
001441881 980__ $$aBIB
001441881 980__ $$aEBOOK
001441881 982__ $$aEbook
001441881 983__ $$aOnline
001441881 994__ $$a92$$bISE